Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Odronextamab plus chemotherapy in patients with previously untreated follicular lymphoma: First results from part 1 of the Phase 3 Olympia-2 study

Kitsada Wudhikarn, Tuba Hacibekiroglu, Jose Angel Hernandez Rivas, Sebastian Grosicki, Jingxian Cai, Jingxiao Chen, Jurriaan Brouwer-Visser, Julia Held, Aafia Chaudhry, Hesham Mohamed, Ashish Risal, Aránzazu Alonso Alonso

Blood (2025) 146 (Supplement 1): 3600.

https://doi.org/10.1182/blood-2025-3600

Published: 2025

Journal Articles

Targeting mitochondrial metabolism to suppress neutrophil overactivation in sepsis: Therapeutic potential of the mitochondrial uncoupler BAM15

Kritsanawan Sae-khow, Awirut Charoensappakit, Patinya Maneesow, Nuntanuj Vutthikraivit, Arsa Thammahong, Kitsada Wudhikarn, Monvasi Pachinburavan, Asada Leelahavanichkul

Blood (2025) 146 (Supplement 1): 2981.

https://doi.org/10.1182/blood-2025-2981

Published: 2025

Journal Articles

Genetic and clinical profiles of chronic lymphocytic leukemia in Thailand: Nationwide insights from the thai lymphoma study group

Ornnicha Sathitakorn, Sirorat Kobbuaklee, Chantiya Chanswangphuwana, Thanawat Rattanathammethee, Nisa Makruasi, Anothai Chintabanyat, Suporn Chuncharunee, Pisa Phiphitaporn, Archrob Khuhapinant, Peerapon Wong, Jakrawadee Julamanee, Chayapa Thookhamme, Lalita Norasetthada, Udomsak Bunworasate, Tanin Intragumtornchai, Kitsada Wudhikarn, Chantana Polprasert

Blood (2025) 146 (Supplement 1): 2122.

https://doi.org/10.1182/blood-2025-2122

Published: 2025

Journal Articles

Excessive neutrophil extracellular traps formation in sepsis induced acute respiratory distress syndrome: Role of citrullinated histone H3 as a surrogate biomarker and clinical implication

Awirut Charoensappakit, Kritsanawan Sae-khow, Patinya Maneesow, Nuntanuj Vutthikraivit, Arsa Thammahong, Monvasi Pachinburavan, Kitsada Wudhikarn, Asada Leelahavanichkul

Blood (2025) 146 (Supplement 1): 4760.

https://doi.org/10.1182/blood-2025-4760

Published: 2025

Journal Articles

Infections in patients with relapsed refractory multiple myeloma receiving idecabtagene vicleucel therapy: A real-world analysis from CIBMTR

Muhammad Bilal Abid, Kitsada Wudhikarn, Qiran Ye, Michael Martens, Abu-Sayeef Mirza, Lohith Gowda, Srinivas Devarakonda, Yvonne Efebera, Zeinab El Boghdadly, Christopher Dandoy, Othman Akhtar, Temitope Oloyede, Christen Ebens, Joshua Hill, Hemant Murthy, Miguel-Angel Perales, Anna Huppler, Jeffery Auletta

Blood (2025) 146 (Supplement 1): 716.

https://doi.org/10.1182/blood-2025-716

Published: 2025

Journal Articles

Detection of MRD Using IGH Assay By NGS after Second Cycle of Chemotherapy in Adult B-Lymphoblastic Leukemia Predicts Poor Clinical Outcomes: Results from a Multicenter Study

Chantana Polprasert, Chantiya Chanswangphuwana, Kitsada Wudhikarn, Wasithep Limvorapitak, Thanawat Rattanathammethee, Thanakrit Piyajaroenkij, Sirorat Kobbuaklee, Adisak Tantiworawit

Blood (2024) 144 (Supplement 1): 5907.

https://doi.org/10.1182/blood-2024-197953

Published: 2024

Journal Articles

Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Prediction of Allogeneic Hematopoietic Stem Cell Transplantation Outcomes of Patients with Hematologic Malignancies

Arsa Thammahong, Kitsada Wudhikarn, Udomsak Bunworasate, Chantiya Chanswangphuwana

Blood (2024) 144 (Supplement 1): 7355.

https://doi.org/10.1182/blood-2024-199390

Published: 2024

Journal Articles

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

Blood (2024) 144 (Supplement 1): 5092.

https://doi.org/10.1182/blood-2024-198455

Published: 2024

Journal Articles

Brentuximab Vedotin in Combination with Methotrexate, L-Asparaginase, and Dexamethasone (B-MAD) As Frontline Treatment for Patients with Extranodal NK/T-Cell Lymphoma

Udomsak Bunworasate, Kitsada Wudhikarn, Thanawat Rattanathammethee, Lalita Norasetthada, Pimjai Niparuck, Suporn Chancharunee, Kanchana Chansung, Archrob Khuhapinant, Peerapon Wong, Pannee Praditsuktavorn, Tontanai Numbenjapon, Jakrawadee Julamanee, Tanin Intragumtornchai

Blood (2023) 142 (Supplement 1): 4434.

https://doi.org/10.1182/blood-2023-181397

Published: 2023

Journal Articles

A Day 14 Endpoint for Acute Gvhd Clinical Trials

Blood (2023) 142 (Supplement 1): 779.

https://doi.org/10.1182/blood-2023-172955

Published: 2023

Journal Articles

High Incidence of Vitamin D Deficiency Among Patients Undergoing Hematopoietic Stem Cell Transplant and a Single Ultra-High Dose Vitamin D Replacement

Chutimon Toemthong, Chantiya Chanswangphuwana, Chantana Polprasert, Sunisa Kongkiatkamon, Panisinee Lawasut, Udomsak Bunworasate, Kitsada Wudhikarn

Blood (2023) 142 (Supplement 1): 6954.

https://doi.org/10.1182/blood-2023-185648

Published: 2023

Journal Articles

Predictors of Cytokine Release Syndrome and Neurotoxicity in Patients with Large B-Cell Lymphoma and Their Impact on Survival

Blood (2023) 142 (Supplement 1): 355.

https://doi.org/10.1182/blood-2023-181181

Published: 2023

Journal Articles

Inherited Germline DNA Repair Gene Defects Are Prevalent Among Thai Patients with Myeloid Neoplasms

Sunisa Kongkiatkamon, Chupong Ittiwut, Thanawat Rattanathammethee, Wanna Chetruengchai, Kitsada Wudhikarn, Sirorat Kobbuaklee, Amornchai Suksusut, Pimjai Niparuck, Noppacharn Uaprasert, Suporn Chuncharunee, Udomsak Bunworasate, Kanya Suphapeetiporn, Ponlapat Rojnuckarin, Chantana Polprasert

Blood (2022) 140 (Supplement 1): 8674–8675.

https://doi.org/10.1182/blood-2022-158118

Published: 2022

Journal Articles

Mucosal Associated Lymphoid Tissue Lymphoma in Thailand, a Nationwide Multicenter Registry and Prognostic Index; Results from the Thai Lymphoma Study Group (TLSG) Registry

Blood (2022) 140 (Supplement 1): 6536–6537.

https://doi.org/10.1182/blood-2022-169944

Published: 2022

Journal Articles

CNS Relapse in T-Cell Lymphoma Index: A Risk Score to Predict Central Nervous System Relapse in Patients with T-Cell Lymphomas

Blood (2022) 140 (Supplement 1): 1481–1484.

https://doi.org/10.1182/blood-2022-160090

Published: 2022

Journal Articles

Epidemiology and Prognostic Index of Ocular Adnexal Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Thailand: Results from the Thai Lymphoma Study Group (TLSG)

Blood (2022) 140 (Supplement 1): 11960–11961.

https://doi.org/10.1182/blood-2022-168346

Published: 2022

Journal Articles

Improvement in Outcomes of Autologous Stem Cell Transplant in Patients with Lymphoma Older Than 70 Years: The Significance of Age in 2020s?

Kitsada Wudhikarn, Bradley K. Johnson, Jose C. Villasboas, Jonas Paludo, David J. Inwards, Luis F. Porrata, Ivana N. Micallef, Stephen M. Ansell, Patrick B. Johnston

Blood (2021) 138 (Supplement 1): 2908.

https://doi.org/10.1182/blood-2021-144507

Published: 2021

Journal Articles

A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse

Blood (2021) 138 (Supplement 1): 1382.

https://doi.org/10.1182/blood-2021-148868

Published: 2021

Journal Articles

Outcomes of Aggressive B Cell Lymphoma Patients with No Evidence of Measurable Disease at the Time of CD19 Chimeric Antigen Receptor T Cell Therapy: The Experience from the CAR T Cell Consortium

Kitsada Wudhikarn, Ana Alarcon Tomas, Jamie Brower, Veronika Bachanova, Richard T. Maziarz, Joseph P. McGuirk, Loretta Nastoupil, David L. Porter, Peter A. Riedell, Miguel-Angel Perales

Blood (2021) 138 (Supplement 1): 2843.

https://doi.org/10.1182/blood-2021-150012

Published: 2021

Journal Articles

Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy

Kitsada Wudhikarn, Jessica R. Flynn, Isabelle Rivière, Mithat Gönen, Xiuyan Wang, Brigitte Senechal, Kevin J. Curran, Mikhail Roshal, Peter G. Maslak, Mark B. Geyer, Elizabeth F. Halton, Claudia Diamonte, Marco L. Davila, Michel Sadelain, Renier J. Brentjens, Jae H. Park

Blood (2021) 138 (7): 531–543.

https://doi.org/10.1182/blood.2020009515

Published: 2021

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Odronextamab plus chemotherapy in patients with previously untreated follicular lymphoma: First results from part 1 of the Phase 3 Olympia-2 study

Targeting mitochondrial metabolism to suppress neutrophil overactivation in sepsis: Therapeutic potential of the mitochondrial uncoupler BAM15

Genetic and clinical profiles of chronic lymphocytic leukemia in Thailand: Nationwide insights from the thai lymphoma study group

Excessive neutrophil extracellular traps formation in sepsis induced acute respiratory distress syndrome: Role of citrullinated histone H3 as a surrogate biomarker and clinical implication

Infections in patients with relapsed refractory multiple myeloma receiving idecabtagene vicleucel therapy: A real-world analysis from CIBMTR

Detection of MRD Using IGH Assay By NGS after Second Cycle of Chemotherapy in Adult B-Lymphoblastic Leukemia Predicts Poor Clinical Outcomes: Results from a Multicenter Study

Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Prediction of Allogeneic Hematopoietic Stem Cell Transplantation Outcomes of Patients with Hematologic Malignancies

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

Brentuximab Vedotin in Combination with Methotrexate, L-Asparaginase, and Dexamethasone (B-MAD) As Frontline Treatment for Patients with Extranodal NK/T-Cell Lymphoma

A Day 14 Endpoint for Acute Gvhd Clinical Trials

High Incidence of Vitamin D Deficiency Among Patients Undergoing Hematopoietic Stem Cell Transplant and a Single Ultra-High Dose Vitamin D Replacement

Predictors of Cytokine Release Syndrome and Neurotoxicity in Patients with Large B-Cell Lymphoma and Their Impact on Survival

Inherited Germline DNA Repair Gene Defects Are Prevalent Among Thai Patients with Myeloid Neoplasms

Mucosal Associated Lymphoid Tissue Lymphoma in Thailand, a Nationwide Multicenter Registry and Prognostic Index; Results from the Thai Lymphoma Study Group (TLSG) Registry

CNS Relapse in T-Cell Lymphoma Index: A Risk Score to Predict Central Nervous System Relapse in Patients with T-Cell Lymphomas

Epidemiology and Prognostic Index of Ocular Adnexal Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Thailand: Results from the Thai Lymphoma Study Group (TLSG)

Improvement in Outcomes of Autologous Stem Cell Transplant in Patients with Lymphoma Older Than 70 Years: The Significance of Age in 2020s?

A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse

Outcomes of Aggressive B Cell Lymphoma Patients with No Evidence of Measurable Disease at the Time of CD19 Chimeric Antigen Receptor T Cell Therapy: The Experience from the CAR T Cell Consortium

Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only